Is TScan Therapeutics, Inc. (TCRX) a Buy, Sell, or Hold?
NASDAQ : TCRX
TScan Therapeutics, Inc. — Insider Trades
$0.767 USD
-$0.01 (-1.26%)
- Volume
- 394.02K
- Average Volume
- 829.65K
- Market Capitalization
- $46.84M
- P/E Ratio
- -0.84
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $2.57
- Year Low
- $0.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.23
Insider Activity Summary (Last 12 Months)
Insiders Buying
14
Insiders Selling
0
Amount of Insider Selling
-$
TCRX Insider Buying/Selling by Quarter
TCRX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Woods Keith | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Nicholson Garry A | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Gruia Gabriela | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Dorton Katina | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Klencke Barbara | director | 2026-05-20 | A-Award | 0.9946 | 2026-05-22 |
| Amello Jason | officer: Chief Financial Officer | 2026-01-20 | A-Award | 1.12 | 2026-01-22 |
| MacBeath Gavin | director, officer: Chief Executive Officer | 2026-01-20 | A-Award | 1.12 | 2026-01-22 |
| Dworak Leiden | officer: See Remarks | 2026-01-20 | A-Award | 1.12 | 2026-01-22 |
| Louis Chrystal | officer: Chief Medical Officer | 2026-01-20 | A-Award | 1.12 | 2026-01-22 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2026-01-20 | A-Award | 1.12 | 2026-01-22 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-12-23 | P-Purchase | 0.8989 | 2025-12-23 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-12-22 | P-Purchase | 0.9 | 2025-12-23 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-12-19 | P-Purchase | 0.8989 | 2025-12-23 |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 3.065 | 2025-08-22 | |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 6 | 2025-08-22 | |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 2.23 | 2025-08-22 | |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 2.49 | 2025-08-22 | |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 1.81 | 2025-08-22 | |
| Dworak Leiden | officer: Principal Accounting Officer | 2025-08-14 | 2.9 | 2025-08-22 | |
| BAKER BROS. ADVISORS LP | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Klencke Barbara | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Nicholson Garry A | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Woods Keith | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Dorton Katina | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Gruia Gabriela | director | 2025-06-30 | A-Award | 1.45 | 2025-07-02 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-05-20 | P-Purchase | 1.2 | 2025-05-21 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-05-19 | P-Purchase | 1.2 | 2025-05-21 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2025-01-03 | A-Award | 3.065 | 2025-02-11 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-01-12 | A-Award | 6 | 2025-02-11 |
| Dworak Leiden | other: Vice President, Finance | 2024-01-12 | A-Award | 6 | 2025-02-11 |
| MacBeath Gavin | director, officer: Chief Executive Officer | 2025-01-03 | A-Award | 3.065 | 2025-02-11 |
| MacBeath Gavin | director, officer: Chief Executive Officer | 2024-01-12 | A-Award | 6 | 2025-02-11 |
| Amello Jason | officer: Chief Financial Officer | 2025-01-03 | A-Award | 3.065 | 2025-02-11 |
| Louis Chrystal | officer: Chief Medical Officer | 2025-01-03 | A-Award | 3.065 | 2025-02-11 |
| Lynx1 Capital Management LP | 10 percent owner | 2024-12-26 | P-Purchase | 0.0001 | 2024-12-30 |
| Lynx1 Capital Management LP | 10 percent owner | 2024-12-13 | P-Purchase | 2.9014 | 2024-12-16 |
| Lynx1 Capital Management LP | 10 percent owner | 2024-12-12 | P-Purchase | 3.0072 | 2024-12-16 |
| Lynx1 Capital Management LP | 10 percent owner | 2024-11-15 | P-Purchase | 4.3442 | 2024-11-19 |
| Klencke Barbara | director | 2024-09-23 | P-Purchase | 5.29 | 2024-09-24 |
| Klencke Barbara | director | 2024-08-26 | P-Purchase | 5.53 | 2024-08-27 |
| Klencke Barbara | director | 2024-08-23 | P-Purchase | 5.69 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 2.49 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 2.49 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 1.81 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 3.27 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 4.85 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 4.85 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 3.27 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | M-Exempt | 1.81 | 2024-08-27 |
| ZDRAVESKI ZORAN | officer: See Remarks | 2024-08-23 | S-Sale | 5.7814 | 2024-08-27 |
| Woods Keith | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Dorton Katina | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Klencke Barbara | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Gruia Gabriela | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Nicholson Garry A | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Nicholson Garry A | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Nicholson Garry A | 2024-06-12 | 0 | 2024-06-14 | ||
| BAKER BROS. ADVISORS LP | director | 2024-06-12 | A-Award | 8.88 | 2024-06-14 |
| Louis Chrystal | officer: Chief Medical Officer | 2024-05-01 | A-Award | 8.62 | 2024-05-03 |
| Louis Chrystal | 2024-04-22 | 0 | 2024-05-02 | ||
| BAKER BROS. ADVISORS LP | director | 2024-04-19 | P-Purchase | 0.0001 | 2024-04-23 |
| BAKER BROS. ADVISORS LP | director | 2024-04-19 | P-Purchase | 0.0001 | 2024-04-23 |
| Lynx1 Capital Management LP | 10 percent owner | 2024-04-19 | P-Purchase | 0.0001 | 2024-04-23 |
| Amello Jason | officer: Chief Financial Officer | 2024-02-01 | A-Award | 5.15 | 2024-02-02 |
| Amello Jason | 2024-01-29 | 0 | 2024-02-02 | ||
| BARBERICH TIMOTHY J | director | 2023-12-19 | P-Purchase | 4.9685 | 2023-12-21 |
| BARBERICH TIMOTHY J | director | 2023-12-18 | P-Purchase | 4.8866 | 2023-12-21 |
| Klencke Barbara | director | 2023-12-14 | P-Purchase | 5.08 | 2023-12-18 |
| Woods Keith | director | 2023-12-06 | A-Award | 6.74 | 2023-12-08 |
| Woods Keith | 2023-12-06 | 0 | 2023-12-08 | ||
| Dworak Leiden | officer: Chief Accounting Officer | 2023-07-21 | A-Award | 2.23 | 2023-07-24 |
| Dworak Leiden | officer: Chief Accounting Officer | 2023-07-21 | 0 | 2023-07-24 | |
| Dworak Leiden | officer: Chief Accounting Officer | 2023-07-21 | 2.9 | 2023-07-24 | |
| Dworak Leiden | officer: Chief Accounting Officer | 2023-07-21 | 1.81 | 2023-07-24 | |
| Dworak Leiden | officer: Chief Accounting Officer | 2023-07-21 | 2.49 | 2023-07-24 | |
| BARBERICH TIMOTHY J | director | 2023-06-13 | A-Award | 2.66 | 2023-06-15 |
| Barton Debora | officer: Chief Medical Officer | 2023-06-13 | A-Award | 2.49 | 2023-06-15 |
| Dorton Katina | director | 2023-06-13 | A-Award | 2.66 | 2023-06-15 |
| Gruia Gabriela | director | 2023-06-13 | A-Award | 2.66 | 2023-06-15 |
| Klencke Barbara | director | 2023-06-13 | A-Award | 2.66 | 2023-06-15 |
| Silver Brian M. | officer: Chief Financial Officer | 2023-06-13 | A-Award | 2.49 | 2023-06-15 |
| MacBeath Gavin | director, officer: Chief Executive Officer | 2023-06-13 | A-Award | 2.49 | 2023-06-15 |
| ZDRAVESKI ZORAN | officer: Chief Legal Officer | 2023-06-13 | A-Award | 2.49 | 2023-06-15 |
| BAKER BROS. ADVISORS LP | director | 2023-06-13 | A-Award | 2.66 | 2023-06-15 |
| BARBERICH TIMOTHY J | director | 2023-06-02 | P-Purchase | 2.6284 | 2023-06-06 |
| EcoR1 Capital, LLC | 10 percent owner | 2023-05-26 | 0 | 2023-06-05 | |
| Lynx1 Capital Management LP | 10 percent owner | 2023-05-31 | S-Sale | 2.5148 | 2023-06-02 |
| Lynx1 Capital Management LP | 10 percent owner | 2023-05-31 | S-Sale | 2.5201 | 2023-06-02 |
| Lynx1 Capital Management LP | 10 percent owner | 2023-05-31 | S-Sale | 2.5075 | 2023-06-02 |
| Lynx1 Capital Management LP | 10 percent owner | 2023-05-31 | 0 | 2023-06-02 | |
| BAKER BROS. ADVISORS LP | director | 2023-06-01 | A-Award | 0.0001 | 2023-06-02 |
| BAKER BROS. ADVISORS LP | director | 2023-06-01 | A-Award | 0.0001 | 2023-06-02 |
| Klencke Barbara | director | 2023-04-06 | A-Award | 2.2 | 2023-04-10 |
| Klencke Barbara | director | 2023-04-06 | 0 | 2023-04-10 | |
| Klencke Barbara | director | 2023-04-06 | 0 | 2023-04-10 | |
| SOUTHWELL DAVID P | director, officer: Chief Executive Officer | 2023-02-02 | A-Award | 1.81 | 2023-02-06 |
| MacBeath Gavin | officer: See Remarks | 2023-02-02 | A-Award | 1.81 | 2023-02-06 |
| ZDRAVESKI ZORAN | officer: Chief Legal Officer | 2023-02-02 | A-Award | 1.81 | 2023-02-06 |
| Barton Debora | officer: Chief Medical Officer | 2023-02-02 | A-Award | 1.81 | 2023-02-06 |